BBIO

BridgeBio Pharma Inc.

Price

$83.95

return (12m)

71.64%

p/e

-22.63

p/bv

-6.25

DIVIDEND YIELD

0.00%

BBIO price

BridgeBio Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BBIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.68%

3 months

19.45%

1 year

71.64%

2 years

233.53%

5 years

71.22%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals BBIO

Valuation

P/E

-22.63

Sector -4.38

Industry -4.38

P/BV

-6.25

Sector 2.02

Industry 2.02

P/Revenue (PSR)

21.95

Sector -4.40

Industry -4.40

EV/EBITDA

-168.25

Sector -263.09

Industry -263.09

EV/EBIT

-166.50

Sector -702.90

Industry -702.90

P/EBITDA

-31.77

Sector -4.39

Industry -4.39

P/EBIT

-31.45

Sector -4.73

Industry -4.73

P/Total Assets

12.86

Sector 1.49

Industry 1.49

P/Net Current Assets

-5.95

Sector -11.70

Industry -11.70

P/Working Capital

77.31

Sector -3.19

Industry -3.19

EPS

-3.53

Sector -2.14

Industry -2.14

BVPS

-12.79

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

94.44%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-41.13%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-41.56%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-67.01%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-97.03%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.20

Sector 0.03

Industry 0.03

Profitability

ROE

27.61%

Sector -65.14%

Industry -65.14%

ROA

-56.84%

Sector -65.53%

Industry -65.53%

ROIC

-56.78%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.23

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-12.05

Sector -6.07

Industry -6.07

Net Debt / EBIT

-11.92

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.48

Sector -1.07

Industry -1.07

Gross Debt / Equity

-0.77

Sector -0.05

Industry -0.05

Equity/Assets

-2.06

Sector 0.41

Industry 0.41

Liabilities/Assets

3.06

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

59.21%

Sector -

Industry -

5Y Earnings CAGR

4.22%

Sector -

Industry -

Fundamentals BBIO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BBIO BridgeBio Pharma Inc.	$83.95	71.26%	0.00%	-22.63	-6.25	27.61%	-97.03%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BBIO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT BridgeBio Pharma

BridgeBio Pharma Inc.

Average Investor10 user rating

4.0 (3 people)

United States

7 years

Founded: 2019

2019

Time since IPO - 7 years

396

Employees

BridgeBio Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $15.65 billion, with shareholders equity totaling $-2.51 billion.

The company employs approximately 396 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, BridgeBio Pharma Inc. reported $713.07 million in revenue, generating net income of $-691.86 million.

Key financial metrics include a P/E ratio of -22.63, a price-to-book (P/B) ratio of -6.25, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BBIO.

Market cap

$15.65 billion

Net worth

$-2.51 billion

$-2,505,890,000.00

Assets

$1.22 billion

$1,217,300,000.00

Total Shares Outstanding

196.00 million

196,000,000

Average Daily Trading Volume

$3.34 million

$3,337,926.00

Sector

Health Care

Industry

Biotechnology

BBIO

BBIO revenue and profits

Financial Results BBIO

DRAG THE FRAME TO SEE MORE DATA

BBIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of BridgeBio Pharma (BBIO) today?

A cotação de BridgeBio Pharma (BBIO) hoje está em US$ 83.95, com uma variação de 71.64% em relação ao último ano. A cotação de BridgeBio Pharma (BBIO) iniciou o ano negociando na casa dos US$ 76.49 e hoje está em US$ 83.95. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de BridgeBio Pharma (BBIO) e dados de ações do Ibovespa e mercados internacionais.

Quando BridgeBio Pharma (BBIO) paga dividendos?

BridgeBio Pharma (BBIO) não distribuiu dividendos no último ano.

Is BridgeBio Pharma (BBIO) a good investment?

Atualmente, BridgeBio Pharma (BBIO) está cotada a US$ 83.95, com um P/L de -22.63, representando um desvio de -1,315% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 71.64 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 71.64%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy BridgeBio Pharma (BBIO) stock?

Investir em ações de BridgeBio Pharma (BBIO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of BridgeBio Pharma (BBIO) yield today?

A rentabilidade de BridgeBio Pharma (BBIO) foi de 2.68% no último mês, 71.64% no último ano e 71.22% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de BridgeBio Pharma (BBIO) hoje, o investimento total seria de US$ 8,395.00, com base na cotação atual de US$ 83.95.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 14,409.18
Em 5 anos: US$ 14,373.92
Em 10 anos: US$ 8,395.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BBIO

BridgeBio Pharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BBIO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BBIO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT BridgeBio Pharma

BridgeBio Pharma Inc.

United States

7 years

2019

396

PROFIT X PRICE BBIO

Financial Results BBIO

BBIO cash flow

Asset, Revenue and Profit Growth - BBIO

BBIO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions